These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8272924)

  • 21. L-carnitine treatment in glutaric aciduria type I.
    Seccombe DW; James L; Booth F
    Neurology; 1986 Feb; 36(2):264-7. PubMed ID: 3945396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of the multicenter spaniel trial (MUST): taurine- and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration.
    Kittleson MD; Keene B; Pion PD; Loyer CG
    J Vet Intern Med; 1997; 11(4):204-11. PubMed ID: 9298474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-carnitine treatment in a seriously ill cancer patient with severe hyperthyroidism.
    Chee R; Agah R; Vita R; Benvenga S
    Hormones (Athens); 2014; 13(3):407-12. PubMed ID: 25079466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].
    Matsui K; Iwamoto H; Ohtsuki N; Kobayashi T; Miyake S; Yamada M
    No To Hattatsu; 1991 Jan; 23(1):32-8. PubMed ID: 1825272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma.
    Iwasa M; Sugimoto R; Ishihara T; Sekoguchi-Fujikawa N; Yoshikawa K; Mifuji-Moroka R; Tanaka H; Kobayashi Y; Hasegawa H; Takei Y
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):433-40. PubMed ID: 26875483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-carnitine addition to dialysis fluid. A therapeutic alternative for hemodialysis patients.
    Vacha GM; Giorcelli G; d'Iddio S; Valentini G; Bagiella E; Procopio A; di Donato S; Ashbrook D; Corsi M
    Nephron; 1989; 51(2):237-42. PubMed ID: 2915763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of L-carnitine in patients with hepatic encephalopathy.
    Malaguarnera M; Pistone G; Elvira R; Leotta C; Scarpello L; Liborio R
    World J Gastroenterol; 2005 Dec; 11(45):7197-202. PubMed ID: 16437672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate-associated hyperammonemia and DL-carnitine supplement.
    Komatsu M; Kodama S; Yokoyama S; Konishi H; Tanaka K; Momota K; Wada H; Matsuo T
    Kobe J Med Sci; 1987 Jun; 33(3):81-7. PubMed ID: 2959815
    [No Abstract]   [Full Text] [Related]  

  • 31. Carnitine deficiency and hyperammonemia associated with valproic acid therapy.
    Ohtani Y; Endo F; Matsuda I
    J Pediatr; 1982 Nov; 101(5):782-5. PubMed ID: 6813444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study.
    Cruciani RA; Dvorkin E; Homel P; Culliney B; Malamud S; Lapin J; Portenoy RK; Esteban-Cruciani N
    J Pain Symptom Manage; 2009 Apr; 37(4):622-31. PubMed ID: 18809275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nearly fatal muscle carnitine deficiency with full recovery after replacement therapy.
    Prockop LD; Engel WK; Shug AL
    Neurology; 1983 Dec; 33(12):1629-31. PubMed ID: 6685837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome.
    Glaze DG; Neul JL; Percy A; Feyma T; Beisang A; Yaroshinsky A; Stoms G; Zuchero D; Horrigan J; Glass L; Jones NE
    Pediatr Neurol; 2017 Nov; 76():37-46. PubMed ID: 28964591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficiency of the carnitine transporter (OCTN2) with partial N-acetylglutamate synthase (NAGS) deficiency.
    Hwu WL; Chien YH; Tang NL; Law LK; Lin CY; Lee NC
    J Inherit Metab Dis; 2007 Oct; 30(5):816. PubMed ID: 17703373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.
    Maldonado C; Guevara N; Silveira A; Fagiolino P; Vázquez M
    J Int Med Res; 2017 Jun; 45(3):1268-1272. PubMed ID: 28425821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.
    Ohtani Y; Ohyanagi K; Yamamoto S; Matsuda I
    J Pediatr; 1988 Mar; 112(3):409-14. PubMed ID: 3346778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical physiological responses to propranolol in a Rett syndrome patient: a case report.
    Santosh PJ; Bell L; Lievesley K; Singh J; Fiori F
    BMC Pediatr; 2016 Nov; 16(1):194. PubMed ID: 27899087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rett syndrome].
    van Urk PR; van den Berg MP; van Royen BJ; Smeets EE; Curfs LM
    Ned Tijdschr Geneeskd; 2014; 158(3):A6686. PubMed ID: 24423488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.